Leanne Berkahn
-
- Lymphoma Diagnosis and Treatment 19
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 10
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment 4
- Hematology top 10%
- Acute Myeloid Leukemia Research 5
-
- CAR-T cell therapy research 4
-
- Acute Lymphoblastic Leukemia research 9
-
- Lung Cancer Treatments and Mutations 5
-
- Medical Imaging Techniques and Applications 4
- Co-authors
- Armand KeatingAnna RuskovaDavid W. ScottRandy D. GascoyneBrian BerryMukesh ChhanabhaiLaurie H. SehnJoseph M. Connors
- Partner nations
- New ZealandAustraliaUnited States
In The Last Decade
Leanne Berkahn
34 papers receiving 464 citations
Peers
Comparison fields: 5 of 64
- Pathology and Forensic Medicine 255
- Genetics 128
- Neurology 124
- Hematology 86
- Oncology 150
Countries citing papers authored by Leanne Berkahn
This map shows the geographic impact of Leanne Berkahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leanne Berkahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leanne Berkahn more than expected).
Fields of papers citing papers by Leanne Berkahn
This network shows the impact of papers produced by Leanne Berkahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leanne Berkahn. The network helps show where Leanne Berkahn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leanne Berkahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 0 | |
| 5 | 2021 | 10 | |
| 6 | 2020 | 4 | |
| 7 | 2019 | 6 | |
| 8 | 2013 | 1 | |
| 9 | Responses and chemotherapy dose adjustment determined by PET-CT imaging: First results from the international response adapted therapy in advanced hodgkin lymphoma (RATHL) study | 2013 | 1 |
| 10 | 2013 | 10 | |
| 11 | 2012 | 30 | |
| 12 | 2012 | 6 | |
| 13 | 2011 | 146 | |
| 14 | 2004 | 27 | |
| 15 | 2003 | 15 | |
| 16 | 2002 | 9 | |
| 17 | 2000 | 5 | |
| 18 | 1999 | 19 | |
| 19 | 1996 | 7 | |
| 20 | 1992 | 23 |
About Leanne Berkahn
Leanne Berkahn is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Public Health, Environmental and Occupational Health, having authored 36 papers that have together received 474 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (5 papers), Lung Cancer Treatments and Mutations (5 papers), Medical Imaging Techniques and Applications (4 papers), CAR-T cell therapy research (4 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (255 citations), Genetics (128 citations), Neurology (124 citations), Hematology (86 citations) and Oncology (150 citations). Leanne Berkahn has collaborated with scholars based in New Zealand, Australia and United States. Frequent co-authors include Armand Keating, Anna Ruskova, David W. Scott, Randy D. Gascoyne, Brian Berry, Mukesh Chhanabhai, Laurie H. Sehn, Joseph M. Connors, Robin Filshie and John Baker. Their work appears in journals such as Blood, Hematological Oncology, Bone Marrow Transplantation, Journal of Clinical Oncology and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.